The Scripps La Jolla Regional Cardiac Arrhythmia Center is currently conducting multi-center cooperative clinical trials on heart failure and arrhythmia management. These include:
- Cardiac resynchronization therapy (biventricular pacing). An investigational defibrillator system for the management of heart failure. Patients who appear to benefit the most from this therapy have a widened QRS complex (bundle branch block) and symptomatic heart failure. While biventricular pacing and ICD systems are now FDA approved, several advances are under development. The Scripps La Jolla Regional Cardiac Arrhythmia Center is participating in several trials to evaluate some of these newest devices and leads. Contact a physician for additional details.
- Atrial defibrillation. An investigational defibrillator for the management of atrial fibrillation and life-threatening ventricular arrhythmias. Currently enrolling.
- Investigational medications. Trials are ongoing for several medications used to treat specific arrhythmias.
- Ablation therapy. A prototype three-dimensional cardiac mapping system is currently being studied.